申请人:Rorer Pharmaceutical Corp.
公开号:US04920227A1
公开(公告)日:1990-04-24
Certain specific substituted benzobicyclic carboxamides and their valuable use as 5-HT3 antagonists having CNS and gastric prokenetic activity void of any significant D.sub.2 receptor binding activity are disclosed.
某些特定的替代苯并环戊二酰胺及其作为5-HT3拮抗剂的宝贵用途被披露,具有中枢神经系统和胃动力活性,且不具有任何显著的D.sub.2受体结合活性。